Mistral Ventures Inc (PINK:MILV) is still going up, pumped by a flurry of press releases and an ongoing promotional campaign.
Yesterday MILV closed up 2.48% at $0.124 with 49 million shares traded – twice the average for MILV. While the closing price was in the green, MILV actually opened higher at $0.125 and couldn’t reach the high from the day before.
The PR which supported MILV yesterday claimed the company had finalized the purchase of a sinusitis formula mentioned in a previous press release. Robert deZanger, CEO of MILV, stated: “We expect to have product manufactured and ready for sale in the next 30-60 days.”[BANNER]
Mr. deZanger went even further, saying that the company anticipates sales in excess of $10 million the first year. The bold statement isn’t based on anything else than the belief of MILV that their product will “command a substantial market share.”
The promotional campaign by SecretPennyStocks is also still going, but other than the press releases and the paid services of the promoter, there isn’t any new information.
It will be interesting how far MILV can ride the wave of self-touting press releases and promotions. Some disclosure of the current financial state of the company may fuel the run further, but it could just as well put a sudden stop to it, depending on what is really going on with MILV.
